Sofituzumab vedotin
Appearance
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | carbohydrate antigen 125 |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Chemical and physical data | |
Molar mass | 144.7 kg/mol |
Sofituzumab vedotin[1] is a monoclonal antibody designed for the treatment of ovarian cancer.[2]
This drug was developed by Genentech/Roche.